Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prendergast

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with GlioblastomaErik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
Molecular Carcinogenesis|July 4, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanismBrianna L Hill, Alyssa N Calder, Joseph P Flemming, et al.
Molecular Cancer Therapeutics|August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the MitochondriaChristopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
Nature|June 17, 2014
Aryl hydrocarbon receptor control of a disease tolerance defence pathwayAlban Bessede, Marco Gargaro, Maria T Pallotta, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with GlioblastomaErik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
Molecular Carcinogenesis|July 4, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanismBrianna L Hill, Alyssa N Calder, Joseph P Flemming, et al.
Molecular Cancer Therapeutics|August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the MitochondriaChristopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
Nature|June 17, 2014
Aryl hydrocarbon receptor control of a disease tolerance defence pathwayAlban Bessede, Marco Gargaro, Maria T Pallotta, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 23